Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Dummer

Showing results (441-450 of 744) with videos related to

Pageof 75
Sort By:
Science Advances|August 14, 2018
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spreadQiaoli Ma, Lothar C Dieterich, Kristian Ikenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trialMadeleine Duvic, Reinhard Dummer, Jürgen C Becker, et al.
Plos One|May 7, 2025
Prognostic and predictive value of IDO expression in metastatic melanoma treated with IpilimumabDagmar von Bubnoff, Christina Schmitt, Simone M Goldinger, et al.
British Journal of Cancer|March 22, 2017
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapyAdi Nosrati, Katy K Tsai, Simone M Goldinger, et al.
BMC Palliative Care|March 15, 2024
Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers - a randomized controlled studyAnnina Seiler, Manuel Amann, Caroline Hertler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitionLucas Basler, Hubert S Gabryś, Sabrina A Hogan, et al.
Melanoma Research|October 31, 2018
Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter studyJoshua Z Drago, Donald Lawrence, Elisabeth Livingstone, et al.
Cancer Research|August 6, 2013
SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesisJulia C Cronin, Dawn E Watkins-Chow, Art Incao, et al.
Journal of Dermatological Science|March 31, 2018
The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axisChu-Fang Chou, Yu-Hua Hsieh, Clinton J Grubbs, et al.
The Oncologist|June 24, 2025
Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanomaAmélie Ciernik, Laure Ciernik, Peter Bonczkowitz, et al.
Pageof 75

Showing results (441-450 of 744) with videos related to

Sort By:
Pageof 75
Science Advances|August 14, 2018
Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spreadQiaoli Ma, Lothar C Dieterich, Kristian Ikenberg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2012
Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: results of a phase II trialMadeleine Duvic, Reinhard Dummer, Jürgen C Becker, et al.
Plos One|May 7, 2025
Prognostic and predictive value of IDO expression in metastatic melanoma treated with IpilimumabDagmar von Bubnoff, Christina Schmitt, Simone M Goldinger, et al.
British Journal of Cancer|March 22, 2017
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapyAdi Nosrati, Katy K Tsai, Simone M Goldinger, et al.
BMC Palliative Care|March 15, 2024
Effects of dignity therapy on psychological distress and wellbeing of palliative care patients and family caregivers - a randomized controlled studyAnnina Seiler, Manuel Amann, Caroline Hertler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2020
Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitionLucas Basler, Hubert S Gabryś, Sabrina A Hogan, et al.
Melanoma Research|October 31, 2018
Clinical experience with combination BRAF/MEK inhibitors for melanoma with brain metastases: a real-life multicenter studyJoshua Z Drago, Donald Lawrence, Elisabeth Livingstone, et al.
Cancer Research|August 6, 2013
SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesisJulia C Cronin, Dawn E Watkins-Chow, Art Incao, et al.
Journal of Dermatological Science|March 31, 2018
The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axisChu-Fang Chou, Yu-Hua Hsieh, Clinton J Grubbs, et al.
The Oncologist|June 24, 2025
Retrospective multicenter analysis of real-life toxicity and outcome of ipilimumab and nivolumab in metastatic uveal melanomaAmélie Ciernik, Laure Ciernik, Peter Bonczkowitz, et al.
Pageof 75